Solid Organ Transplant Rejection

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Direct Biologics
Direct BiologicsTX - Austin
1 program
ExoFloN/A1 trial
Active Trials
NCT05215288No Longer Available

Clinical Trials (1)

NCT05215288Direct BiologicsExoFlo

Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients

N/ANo Longer Available

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space